'Trading Nation' Traders Weigh In On FAANG Stocks

May 13, 2021 4:28 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
'Trading Nation' Traders Weigh In On FAANG Stocks

On CNBC's "Trading Nation," Todd Gordon of TradingAnalysis.com and Boris Schlossberg of BK Asset Management spoke about FAANG stocks.

Gordon said that Apple Inc (NASDAQ:AAPL) is in the best position for a potential rebound and Amazon.com, Inc. (NASDAQ:AMZN) is right behind it. He analyzed the monthly time frame to reach that conclusion.

See also: How To Buy Apple Stock

Gordon sees weakness in Netflix Inc (NASDAQ:NFLX). He is concerned about the stock because it's losing market share and picking up competitors.

Schlossberg said Netflix is weak because it's very expensive to produce new content and there a lot of competitors in the space. Subscriber growth has slowed remarkably and Schlossberg sees a lot of weakness, capital expenditure and cash burn ahead.

He likes Alphabet Inc Class A (NASDAQ:GOOGL) (NASDAQ:GOOG) because the ad buying business could not be better. He would take a long position in Alphabet and a short position in Netflix.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Tech Media Trading Ideas

Related Articles

Apple, Google's Privacy Updates Have Massively Impacted Advertising Strategies: CNBC

Dan Ives Says Apple Is Headed To $3 Trillion Market Cap

The current product development cycle will be the biggest one over the last decade for Apple Inc (NASDAQ: AAPL), Wedbush analyst Dan Ives said Monday on CNBC's "Squawk Box." read more

When Will Apple Buy A Big Company?

Jim Cramer spoke on CNBC's "Mad Money" with Tim Cook, the CEO of Apple Inc. (NASDAQ: AAPL), about the future of the company. read more

Apple Looked To Employ Doctors, Launch Primary-Care Clinics In Bid To Dominate Health Sector: WSJ

Apple Inc (NASDAQ: AAPL) planned to offer its own primary-care medical service, complete with doctors in the tech giant's employ, to roll out a subscription-based personalized health program, the Wall Street Journal read more